Minerva Non Current Liabilities Total vs Short Term Debt Analysis
NERV Stock | USD 2.55 0.22 9.44% |
Minerva Neurosciences financial indicator trend analysis is infinitely more than just investigating Minerva Neurosciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Minerva Neurosciences is a good investment. Please check the relationship between Minerva Neurosciences Non Current Liabilities Total and its Short Term Debt accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.
Non Current Liabilities Total vs Short Term Debt
Non Current Liabilities Total vs Short Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Minerva Neurosciences Non Current Liabilities Total account and Short Term Debt. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Minerva Neurosciences' Non Current Liabilities Total and Short Term Debt is 0.14. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Minerva Neurosciences, assuming nothing else is changed. The correlation between historical values of Minerva Neurosciences' Non Current Liabilities Total and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Minerva Neurosciences are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Non Current Liabilities Total i.e., Minerva Neurosciences' Non Current Liabilities Total and Short Term Debt go up and down completely randomly.
Correlation Coefficient | 0.14 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Non Current Liabilities Total
Short Term Debt
Most indicators from Minerva Neurosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Minerva Neurosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.At this time, Minerva Neurosciences' Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to climb to 0.00 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (3.68) in 2024.
2023 | 2024 (projected) | Extraordinary Items | 8.5M | 7.5M | Reconciled Depreciation | 29.6K | 57.8K |
Minerva Neurosciences fundamental ratios Correlations
Click cells to compare fundamentals
Minerva Neurosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Minerva Neurosciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 77.5M | 57.6M | 77.1M | 55.1M | 56.9M | 88.0M | |
Other Current Liab | (41.2B) | 2.1M | 965.7K | 407.9K | 1.5M | 1.6M | |
Total Current Liabilities | 6.6M | 3.2M | 2.8M | 1.4M | 3.3M | 4.4M | |
Total Stockholder Equity | 27.8M | 52.7M | 8.0M | (20.0M) | (28.5M) | (27.0M) | |
Net Debt | (21.1M) | (25.2M) | (60.8M) | 37.6M | 41.0M | 43.1M | |
Retained Earnings | (286.7M) | (284.8M) | (334.7M) | (366.8M) | (396.8M) | (377.0M) | |
Cash | 21.4M | 25.4M | 60.8M | 36.1M | 41.0M | 34.7M | |
Cash And Short Term Investments | 45.9M | 25.4M | 60.8M | 36.1M | 41.0M | 51.4M | |
Common Stock Total Equity | 3.9K | 3.9K | 3.9K | 4.3K | 4.9K | 3.0K | |
Common Stock Shares Outstanding | 4.9M | 5.1M | 5.3M | 5.3M | 6.5M | 4.6M | |
Liabilities And Stockholders Equity | 77.5M | 57.6M | 77.1M | 55.1M | 56.9M | 88.0M | |
Other Current Assets | 1.3B | 2.1B | 1.4B | 4.0M | 989.9K | 940.4K | |
Other Stockholder Equity | 314.5M | 337.5M | 342.7M | 346.8M | 368.4M | 264.5M | |
Total Liab | 49.7M | 5.0M | 69.1M | 75.1M | 85.4M | 42.7M | |
Total Current Assets | 47.1M | 27.4M | 62.2M | 40.2M | 42.0M | 52.9M | |
Common Stock | 3.9K | 4K | 4.3K | 534.0 | 699.0 | 664.05 | |
Property Plant And Equipment Net | 278K | 101.8K | 51.1K | 16.3K | 10.9K | 10.3K | |
Accounts Payable | 2.3M | 995.6K | 1.9M | 969.7K | 1.8M | 1.5M | |
Non Current Assets Total | 30.4M | 30.2M | 14.9M | 14.9M | 14.9M | 27.9M | |
Non Current Liabilities Total | 43.1M | 1.8M | 66.3M | 73.7M | 82.0M | 41.8M | |
Property Plant And Equipment Gross | 278.0K | 101.8K | 0.0 | 16.3K | 18.8K | 17.8K | |
Short Term Debt | 4.0M | 41.2B | 173K | 111.2K | 127.9K | 121.5K | |
Property Plant Equipment | 33.5K | 16.0K | 101.8K | 16.3K | 18.8K | 36.8K | |
Other Liab | 43.0M | 1.8M | 66.3M | 73.7M | 84.8M | 89.0M | |
Net Tangible Assets | (2.3M) | 22.6M | (6.9M) | (34.9M) | (31.4M) | (29.9M) | |
Retained Earnings Total Equity | (164.4M) | (214.6M) | (286.7M) | (284.8M) | (256.3M) | (269.1M) | |
Capital Surpluse | 296.0M | 304.8M | 314.5M | 337.5M | 388.1M | 278.9M | |
Non Current Liabilities Other | 41.2M | 41.3M | 66.3M | 73.7M | 82.0M | 41.9M | |
Net Invested Capital | 27.8M | 52.7M | 8.0M | (20.0M) | (28.5M) | (27.0M) | |
Net Working Capital | 40.5M | 24.3M | 59.4M | 38.8M | 38.7M | 46.9M |
Pair Trading with Minerva Neurosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Minerva Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Minerva Neurosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Minerva Stock
0.81 | EQ | Equillium | PairCorr |
The ability to find closely correlated positions to Minerva Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Minerva Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Minerva Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Minerva Neurosciences to buy it.
The correlation of Minerva Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Minerva Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Minerva Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Minerva Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Minerva Stock analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
CEOs Directory Screen CEOs from public companies around the world | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Minerva Neurosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Minerva Neurosciences. If investors know Minerva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Minerva Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.43) | Return On Assets (0.30) | Return On Equity (6.75) |
The market value of Minerva Neurosciences is measured differently than its book value, which is the value of Minerva that is recorded on the company's balance sheet. Investors also form their own opinion of Minerva Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Minerva Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Minerva Neurosciences' market value can be influenced by many factors that don't directly affect Minerva Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Minerva Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Minerva Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Minerva Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.